What is the Best Latent Structure of Negative Symptoms in Schizophrenia? A Systematic Review.

Schizophrenia Bulletin Open Pub Date : 2021-04-21 eCollection Date: 2021-01-01 DOI:10.1093/schizbullopen/sgab013
Bernardo Haguiara, Gabriela Koga, Elton Diniz, Lais Fonseca, Cinthia H Higuchi, Simão Kagan, Acioly Lacerda, Christoph U Correll, Ary Gadelha
{"title":"What is the Best Latent Structure of Negative Symptoms in Schizophrenia? A Systematic Review.","authors":"Bernardo Haguiara,&nbsp;Gabriela Koga,&nbsp;Elton Diniz,&nbsp;Lais Fonseca,&nbsp;Cinthia H Higuchi,&nbsp;Simão Kagan,&nbsp;Acioly Lacerda,&nbsp;Christoph U Correll,&nbsp;Ary Gadelha","doi":"10.1093/schizbullopen/sgab013","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Determining the best latent structure of negative symptoms in schizophrenia could benefit assessment tools, neurobiological research, and targeted interventions. However, no review systematically evaluated studies that assessed and validated latent models of negative symptoms.</p><p><strong>Objective: </strong>To identify and evaluate existing latent structure models in the literature of negative symptoms and to determine the best model.</p><p><strong>Method: </strong>Systematic search of MEDLINE, EMBASE, and Scopus on July 19, 2020, for confirmatory factor analysis models of negative symptoms in patients with schizophrenia. The available evidence was assessed through 2 sets of criteria: (1) study design quality-based on negative symptoms assessment and modeling strategy and (2) psychometric quality and model fit-based on fit indices and factor definition quality.</p><p><strong>Results: </strong>In total, 22 studies (<i>n</i> = 17 086) from 9 countries were included. Studies differed greatly regarding symptom scales, setting, and sample size (range = 86-6889). Dimensional models included 2-6 factors (median = 4). Twelve studies evaluated competing models and adopted appropriate instruments to assess the latent structure of negative symptoms. The 5-factor and hierarchical models outperformed unitary, 2-factor, and 3-factor models on all direct comparisons, and most of the analyses derived from the Brief Negative Symptom Scale. Considering the quality criteria proposed, 5-factor and hierarchical models achieved excellent fit in just one study.</p><p><strong>Conclusions: </strong>Our review points out that the 5-factor and hierarchical models represent the best latent structure of negative symptoms, but the immaturity of the relevant current literature may affect the robustness of this conclusion. Future studies should address current limitations regarding psychometric properties and also address biological and clinical validity to refine available models.</p>","PeriodicalId":21348,"journal":{"name":"Schizophrenia Bulletin Open","volume":" ","pages":"sgab013"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1093/schizbullopen/sgab013","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Schizophrenia Bulletin Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/schizbullopen/sgab013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

Background: Determining the best latent structure of negative symptoms in schizophrenia could benefit assessment tools, neurobiological research, and targeted interventions. However, no review systematically evaluated studies that assessed and validated latent models of negative symptoms.

Objective: To identify and evaluate existing latent structure models in the literature of negative symptoms and to determine the best model.

Method: Systematic search of MEDLINE, EMBASE, and Scopus on July 19, 2020, for confirmatory factor analysis models of negative symptoms in patients with schizophrenia. The available evidence was assessed through 2 sets of criteria: (1) study design quality-based on negative symptoms assessment and modeling strategy and (2) psychometric quality and model fit-based on fit indices and factor definition quality.

Results: In total, 22 studies (n = 17 086) from 9 countries were included. Studies differed greatly regarding symptom scales, setting, and sample size (range = 86-6889). Dimensional models included 2-6 factors (median = 4). Twelve studies evaluated competing models and adopted appropriate instruments to assess the latent structure of negative symptoms. The 5-factor and hierarchical models outperformed unitary, 2-factor, and 3-factor models on all direct comparisons, and most of the analyses derived from the Brief Negative Symptom Scale. Considering the quality criteria proposed, 5-factor and hierarchical models achieved excellent fit in just one study.

Conclusions: Our review points out that the 5-factor and hierarchical models represent the best latent structure of negative symptoms, but the immaturity of the relevant current literature may affect the robustness of this conclusion. Future studies should address current limitations regarding psychometric properties and also address biological and clinical validity to refine available models.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
精神分裂症阴性症状的最佳潜伏结构是什么?系统评价。
背景:确定精神分裂症阴性症状的最佳潜伏结构有助于评估工具、神经生物学研究和针对性干预。然而,尚无综述系统地评价评估和验证阴性症状潜在模型的研究。目的:对文献中已有的阴性症状潜在结构模型进行识别和评价,确定最佳模型。方法:于2020年7月19日系统检索MEDLINE、EMBASE和Scopus,获取精神分裂症患者阴性症状的验证性因素分析模型。现有证据通过两套标准进行评估:(1)基于阴性症状评估和建模策略的研究设计质量;(2)基于拟合指数和因子定义质量的心理测量质量和模型拟合。结果:共纳入来自9个国家的22项研究(n = 17086)。研究在症状量表、环境和样本量方面差异很大(范围= 86-6889)。维度模型包括2-6个因素(中位数= 4)。12项研究评估了相互竞争的模型,并采用适当的工具来评估阴性症状的潜在结构。在所有直接比较中,5因素和分层模型都优于单一、2因素和3因素模型,并且大多数分析来自简短阴性症状量表。考虑到所提出的质量标准,5因素和分层模型仅在一项研究中就获得了极好的拟合。结论:我们的综述指出,5因素和层次模型代表了阴性症状的最佳潜在结构,但目前相关文献的不成熟可能会影响这一结论的稳健性。未来的研究应解决目前关于心理测量特性的局限性,并解决生物和临床有效性,以完善现有模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Kenya Psychosis-Risk Outcomes Study (KePROS): Development of an Accelerated Medicine Partnership Schizophrenia (AMP SCZ)-Aligned Project in Africa Schizophrenia spectrum disorders (SSD): an empirical benchmark study of real-world diagnostic accuracy and reliability among leading international psychiatrists Predictors of Long-Acting Injectable Antipsychotic Medication Use in Patients with Schizophrenia Spectrum, Bipolar, and Other Psychotic Disorders in a United States Community-based, Integrated Health System Childhood Anxiety Symptoms as a Predictor of Psychotic Experiences in Adolescence in a High-Risk Cohort for Psychiatric Disorders Add-on Sodium Benzoate and N-Acetylcysteine in patients with early schizophrenia spectrum disorder: a multicentre, double-blind, randomised placebo controlled feasibility trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1